| Name | Title | Contact Details |
|---|---|---|
Kyle Haraldsen |
Chief Technical Operations Officer | Profile |
F-star is a clinical-stage biopharmaceutical company committed to delivering life-changing treatments to cancer patients.
Veritas Pharma Inc (trading symbol CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is an early stage pharmaceutical company developing innovative cannabinoid prescription medicines to treat medical conditions such as pain, emesis (nausea/vomiting), glaucoma, and epilepsy. Using a ‘lean and mean’ approach to product development, the company aims to select candidate medicines using classical pharmacology techniques and then immediately evaluate them in the clinic to maximize both product value and shareholder return. Veritas’s scientists are an inter-disciplinary team that consists of chemists, pharmacologists, anesthetists, and clinical pharmacologists. Their focus is to use their knowledge to streamline the development of cannabis based treatments to capture considerable market share. Also through its wholly owned subsidiary, Sechelt Organic Marijuana Corp., has applied to Health Canada for a medical marijuana production and distribution license under the Marihuana for Medical Purposes Regulations (the “MMPR“).
ERT is a global company specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.
Apicore, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Process Design Corp. is a Carson City, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.